TABLE 3.
Patient characteristics (N = 1397) | OR [95% CI] |
---|---|
Age (y) | |
18–30 | Ref |
30–60 | 0.71 [0.59-0.87] |
>60 | 0.67 [0.55-0.83] |
Gender (female) | 1.13 [1.01-1.27] |
BMI (kg/m2) | |
<20 | 1.03 [0.73-1.44] |
20–25 | Ref |
>25 | 0.93 [0.83-1.04] |
Underlying nephropathy | |
Diabetic | 0.40 [0.31-0.51] |
Glomerulonephritis | 0.69 [0.58-0.81] |
Interstitial nephritis | 0.95 [0.77-1.17] |
PKD | Ref |
Systemic disease | 0.30 [0.19-0.46] |
Uropathy | 1.27 [0.90-1.76] |
Vascular | 0.46 [0.36-0.58] |
Miscellaneous | 0.68 [0.51-0.88] |
Unknown | 0.51 [0.42-0.62] |
Diabetes | 0.56 [0.46-0.66] |
Cardiovascular disease | 0.52 [0.44-0.61] |
Tobacco (smoker) | 0.79 [0.71-0.89] |
Hypertension | 0.89 [0.79-1.00] |
Positive hepatitis C serology | 0.43 [0.25-0.68] |
Positive CMV serology | 0.75 [0.67-0.84] |
HLA antibody class I and/or II > 0% | 0.76 [0.66-0.87] |
Blood group | |
B | 0.75 [0.61-0.90] |
Others | Ref |
Donor source (living donor) | 4.57 [3.99-5.22] |
EDI (quintile 5) | 0.60 [0.52-0.68] |
Factors associated with preemptive kidney transplantation.
BMI, body mass index; CI, confidence interval; CMV, cytomegalovirus; OR, odds ratio; PKD, polycystic kidney disease.